chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1 of 4 pts vaxed from the same DTP lot# had adverse event;pt vaxed on 20OCT94 recvd DTP only-brought to MD office 21OCT had fever of 100.4 & 5cm red area w/formed edge (not hive like) surrounding inj site appears like ringworm
Pt is 12yo who received a Dtap vaccine instead of a Tdap for his age. No complications to pt. Pt mother and MD were notified right away.
No adverse event. Pt was given a combi vaccine which included DTAP, Hep B and IPV. Pt was also given single dose I.P.V. Pt was suppose to get DTAP only. Parent notified. Pt has no reaction to vaccine.
Presented to medical clinic nurse Only Immun. requesting varicella and tetanus shots for school on 9/5/2008. Varicella and Tdap were administered by RN without reviewing contraindications for administration of varicella while on immuno suppressant. Notified per  children's 9/29/08, pt developed chicken pox, Acyclovir given.
Patient developed diarrhea, vomiting one day after vaccine (varicella) was given. Diarrhea watery. Also c/o of subjective fever, chills, and dizziness. No rash reported.
Rt upper arm is 19.5 cm at mid bicep (17 cm at mid bicep on the left). Swelling/redness and warmth extending inferiorly from site of vaccine at the Rt. deltoid and involved entire Rt upper arm. Only very mild tenderness.
red blotches on shoulders, face, chest, neck; like a pimple; red, itchy neck; itchy neck; This case was reported by a consumer via call center representative and described the occurrence of erythema in a 52-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.   On 10th December 2019, the patient received the 1st dose of Shingrix and Influenza vaccine Quadrivalent 2019-2020 season. On 17th December 2019, 7 days after receiving Shingrix and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced erythema and pruritus. On 18th December 2019, the patient experienced red blotches and pimple. On an unknown date, the outcome of the erythema, pruritus, red blotches and pimple were not recovered/not resolved.   It was unknown if the reporter considered the erythema, pruritus, red blotches and pimple to be related to Shingrix and Influenza vaccine Quadrivalent 2019-2020 season.  Additional case details were reported as follows: The patient received Shingrix and a preservative free, quadrivalent flu vaccine from an unknown manufacturer and had a red, itchy neck. The patient had red blotches, like a pimple, on his shoulders, chest, neck and face.  The reporter did not consent to follow up. The reporter did not had any other information for the vaccines in this adverse event.
Inside her lower right eyelid developed a red blister on the inside of her eye that was bloody red; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD BLISTER (Inside her lower right eyelid developed a red blister on the inside of her eye that was bloody red) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036C21A and 050C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD BLISTER (Inside her lower right eyelid developed a red blister on the inside of her eye that was bloody red). At the time of the report, BLOOD BLISTER (Inside her lower right eyelid developed a red blister on the inside of her eye that was bloody red) outcome was unknown.            No relevant concomitant product were reported.  No treatment information was provided.
Afib episode began around 8:oo PM. HR highly variable-between 55 and 140 bpm. Treated with Diltiazem 30mg. q2hrsX2 then 4hrsx1, then 8 hrs.  Sinus Rhythm restored after 12 hrs.
Chills starting at 3:00 am on 04/08/2021, body aches,  Heart beat of 106 at 7:30 am after lying in bed.  Blood pressure of 84/59 at 11:00 am and heart beat down.  Feeling weak and very poorly and very tired.
After vaccine given & nurse left room, mom called out for help. NP walked into room and patient was having seizure tonic-clonic lasting < 30 seconds. Patient was post-ictal for several minutes and then recovered to normal behavior.
@1500 12OCT95 whelps @ site 3x7cm; 13OCT 7AM 5x10 cm whelp @ the site of the inj lt deltoid
Migraine started at 2:30 same day as the vx.  Shortly after became lethargic. By 10pm felt feverish but temp wasn?t taken. Overnight had severe chills, sweating, nausea and migraine which persisted until approx 3pm on Dec. 3rd. Dizziness persisted, also loss of appetite and brain fog. Awoke Dec. 4th with pain under left arm, armpit area (lymph node). Left side of my face was hot while the right side was a normal temp. Sweating excessively but no fever suspected. Still have loss of appetite. Dec. 5th Only remaining symptom is pain in armpit. Soreness at injection site has occurred throughout.
Started with fatigue, dizziness, red face, headache on 1/6/2021 Upon waking on 1/7/2021, Whole body pains/ aches, soreness in all joints and worse on whole left side of body, extremely tired  and headache
Sore Throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore Throat). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat) outcome was unknown.            No treatment information was provided. No relevant concomitant medications were reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) is not applicable.
This spontaneous report was received from Registered Nurse who reported that on unspecified dates a unknown number of patients (ages and gender not reported) were vaccinated with a dose of M-M-R II (HSA) which were improperly stored. No adverse effects were reported. This report is linked to MARRS 1410USA009955, 1410USA009956, 1410USA009957, 1410USA009958, 1410USA009959 and 1410USA004588. Additional information has been requested.
This spontaneous report was received from a Licensed Practical Nurse referring multiple unspecified patients of unknown age and genders whom on unknown dates, received unspecified doses of improperly stored VAQTA (Lot #, doses, route and sites of administration not reported). This is one of 8 reports from the same source. No additional information provided. Additional information has been requested.
Shortness of breath doing basic things; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 04May2021 at 13:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included seizure disorder, migraines, post-traumatic stress disorder (ptsd), depression, gastroesophageal reflux disease (gerd), over active bladder and allergic to penicillin and sulfas. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included oxybutynin hydrochloride (DITROPAN), fluoxetine hydrochloride (PROZAC), clonazepam (CLONOPIN), topiramate (TROKENDI XR) and gabapentin (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received silybum marianum (DILATIN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 13:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 05May2021, the patient experienced shortness of breath doing basic things. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event shortness of breath doing basic things was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Severe hives all over, which lasted for three days.  I was given both IV and a prescription for prednisone, and had to take Benadryl, Zyrtec, and Zantac to control them.
This spontaneous report was received from a licensed practical nurse and refers to a unspecified number of patients of unknown age and gender. There was no information about patients' concomitant medications, pertinent medical histories, drug reactions or allergies provided. On an unknown dates, the patients were vaccinated with improperly stored ROTATEQ orally (lot# K022992, expiration date 30-JUN-2016, dose was not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Dose 1 given 4/13, dose 2 given 5/4, symptomatic covid infection identified 7/22/21
29OCT92 generalized weakness prostration chills, fevers x 4 days; t99.4; 2NOV92 has not improved significantly-admitted to ER-nausea & vomiting;
devel fever 25JUN98-had grand mal sz for approx 2-3min;taken to ER;CXR negative;UA negative;fever cont for 2 wk p/episode, was told by MD was caused by vaccine;
Several minutes after receiving anthrax vaccination started sneezing, noticed hives on chest and neck, and started feeling like there was some swelling of the tongue and a little difficulty swallowing. He was given 50mg BENADRYL PO shortly thereafter but continued to feel worse. He was seen by a PA and was recommended to be evaluated further at the local ED. He was seen there, treated with H2 blocker and steroids and discharged the same day. The following day he reports some swelling of the eyes but no swelling of the throat or difficulty swallowing.
Presented to ED 11/11/2021 via EMS from Nursing Home after being found unresponsive. EMS states she was pulseless about 20 minutes prior to the code. EMS noted she was in asystole and PEA wide complex. In ED note, it states that the patient received a flu shot Tuesday, 11/9/2021 and had been complaining of SOB since that time.
Shingles vaccine, Shingles/ suspected vaccination failure; Loss of mobility, wheelchair; Stroke; Shingles; Incontinence; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included methylenetetrahydrofolate reductase gene mutation (MTHFR).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), immobile (serious criteria disability and GSK medically significant), stroke (serious criteria GSK medically significant), shingles and incontinence. On an unknown date, the outcome of the vaccination failure, immobile, stroke, shingles and incontinence were unknown.   The reporter considered the vaccination failure, immobile, stroke, shingles and incontinence to be possibly related to Shingles vaccine.  Additional details were reported as follows: The patient was reporter's uncle. The age at vaccination was not reported. The patient did not have shingles exposure before the shot. The patient got the new shingles vaccine. The reporter stated that the patient's vaccine injuries from that deadly shot were too numerous to mention included Shingles, stroke, loss of mobility (wheelchair), incontinence and much more.  The reporter stated that the people with Methylenetetrahydrofolate reductase (MTHFR) should never be vaccinated. Polio, of course, and we did not have a booster for that. The reporter worked with Big Pharma and said he or she know them inside and out. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation for shingles were unknown at the time of reporting.
6/26/2018 Painless erythema, warmth, and swelling to left deltoid approximately the size of a deck of cards no fever or other symptoms. Taken to Dr. and treatment ibuprofen and to begin KEFLEX oral TID if continues the next day. 6/27/2018 swelling, erythema, and warmth decreased and KEFLEX started. 6/28/2018 all symptoms to left deltoid resolved. 6/29/2018 patient awoke with headache from temple to temple around back of the head and sleepiness. Physician called and follow up appointment same day, which is today @ 350pm. Below recovery section unknown due to follow up appointment today.
I felt symptoms on Jan 4th, 2023 after riding with a family member who also had symptoms prior to mine. I experienced headache, chills fever, severe coughing, a very sticky clear mucus, nasal drip in the back of my throat, loss of appetite, extreme fatigue, joint pain and thirst. I requested care and medication from my primary care clinic and received an antibiotic. I took 2 pills a couple times a day for several days. My symptoms resolved after a week and a half.
Flu like symptoms for two days after. Developed red rash on top of both forearms, Hives in various places on body. Sores inside mouth.
I had an extreme reaction To the Shingrix Shingle shot -- within an hour after I received the shot I was having trouble breathing and had heart palpitations that lasted into the next day.   I called the parent company GSK to report and to ask what type of protection I had after 1 shot - they gave me a run around and 2 different people told me that they had NO data on protection from one shot - so unethical plus I don't believe it.  As a consumer I have a right to that information.
This spontaneous report was received from a nurse via company representative regarding an unknown age male patient. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. On an 30-JUL-2018, the patient was vaccinated with a dose of VAQTA 25/0.5 for routine vaccination (frequency, lot#, expiration date and route of administration were not reported). On the same date, within one hour of administration of the dose of VAQTA the patient developed chest tightness. The patient sought medical attention. The outcome of the event was not reported. The causal relationship between VAQTA and the event was not reported.
New onset of lesions 10-days post SPV. Several, slightly pruritic papules (axilla, elbow and abdomen) with no vesicles, but one crusted lesion in axilla. No systemic symptoms.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A 76 year-old female patient received bnt162b2 (BNT162B2), administration date 28Jan2021 (Lot number: EL3302) at the age of 75 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "sore arm".  Additional information: It was reported that, patient called because she has question about the Covid vaccine and she has experienced adverse events. She has a question about long term side effects, she had the first and second dose of the Covid Vaccine. First dose on 28Jan2021, Second dose on 25Feb2021, and she also had booster on 01Nov2021. She had a sore arm after first two doses and after booster shot, after a month she experienced joint pain, shoulder and knee joint pain. Caller wants to know if this delayed reaction are from the vaccine. No any prior Vaccinations (within 4 weeks), no any other vaccinations within four weeks prior to the first administration date of the suspect vaccine.  No follow-up attempts are possible. No further information is expected.
Very little sore arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very little sore arm after first dose) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Very little sore arm after first dose). At the time of the report, PAIN IN EXTREMITY (Very little sore arm after first dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was not on concomitant medication.  Treatment information was not provided by reporter.   This case was linked to MOD-2021-328618 (Patient Link).
I don?t believe I suffered an adverse event. Rash began before vaccination, worsened during and after vaccination, strep throat (no test) 4 days following vaccination.  V-safe online reporting system does not allow for nuance in answers. I answered that I was sick, which was true, but could not indicate it was unrelated to the vaccine.
This spontaneous report was received from a registered nurse referring to 2 patients of unknown age and gender. The patients' pertinent medical history, concurrent conditions and concomitant medications were not reported. On 15-SEP-2016, the patients were vaccinated with doses of VARIVAX (dosing details not known) (lot # L048465, expiry date: 02-DEC-2017; lot # M009765, expiry date: 23-FEB-2018) that underwent temperature excursions prior to administration. The administered doses experienced a maximum temperature excursion of 24.1 degrees Fahrenheit for 17.75 hours. The dates for the excursions happened sometime during the time frame started on an unknown date in May 2016 and ended on 14-SEP-2016. No known adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Achy after 1st dose; Didn't feel well after 1st dose; Possible improper reconstitution technique 2nd dose; Possible improper reconstitution technique 2nd dose; This case was reported by a physician via call center representative and described the occurrence of pain in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On 3rd February 2023, the patient received the 2nd dose of Shingrix. On 3rd February 2023, not applicable after receiving Shingrix and unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the patient experienced pain and feeling unwell. On an unknown date, the outcome of the pain and feeling unwell were recovered/resolved and the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   It was unknown if the reporter considered the pain and feeling unwell to be related to Shingrix.     Additional Information: GSK Receipt Date: 16-FEB-2023 Reporter's Comments: The patient self-report this case. She received her first Shingrix dose on an unknown date in 2022.  She was achy and did not feel well afterwards. Within six months, on 3rd February 2022 she received her second Shingrix dose.  She did not have any adverse effects.  She was concerned the pharmacist may have used improper reconstitution technique. She did not see the pharmacist wipe off the top of the vial or mix/swirl the vial during reconstitution. Nothing else was reported.  The reporter did not consent to follow up. Additional supportive information: The patient had concerned the pharmacist may have used improper reconstitution technique. She did not see the pharmacist wipe off the top of the vial or mix/swirl the vial during reconstitution, which led to Inappropriate reconstitution technique and Incorrect dose administered.
Vaccine administered beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered beyond use date after the thaw process) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     It was unknown if the patient had ever been diagnosed or tested positive for COVID-19. It was reported, acute illness at the time of vaccination and up to one month before and chronic or long-standing health conditions were unknown.     On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 27-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 47 years and 10 months.   No concomitant drug information was provided.  There was no adverse reaction noted or reported regarding these administrations. Vaccine Ndc code was reported as 80777-0273-99.  No treatment drug information was provided.
Signs/Symptoms: throat tight/swollen, extremely sleepy  Treatment: EMS Called - Patient refused transport.
Patient complained of left arm pain radiating to jaw and temples radiating to neck pain after injection; Patient complained of left arm pain radiating to jaw and temples radiating to neck pain after injection; Patient complained of left arm pain radiating to jaw and temples radiating to neck pain after injection; Patient complained of left arm pain radiating to jaw and temples radiating to neck pain after injection; This is a spontaneous report form a contactable physician. A 45-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number: EL0142, expiry date: not reported) intramuscular, on 07Jan2021 07:30 AM on Arm Left at a single dose for COVID-19 immunization. COVID-19 vaccine was administered at a hospital. Medical history was not reported. It was unknown if patient was pregnant at the time of vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. Concomitant medications were not reported. On 08Jan2021 07:30 AM, the patient complained of left arm pain radiating to jaw and temples radiating to neck pain after injection. Treatment was not received for the adverse events. Outcome of the events was unknown.
Sore arm. Body aches and stiffness in joints Tiredness  Everything  only lasted  24 hours and I felt fine afterwards.